Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q1 2015 · 10-Q
Revenue$108.48M$108.48M+26.6% vs Q1 2014 Net Income$23.91M$23.91M−12.8% vs Q1 2014 EPS Diluted$0.64$0.64−13.5% vs Q1 2014 Gross Profit$73,066,000+19.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flow$35,718,000+9.6% Free Cash Flowderived$30,813,000+7.1% Margins · derivedGross margin67.4%−4.0 pt vs Q1 2014
Operating margin32.5%−13.5 pt vs Q1 2014
Net margin22.0%−10.0 pt vs Q1 2014
ended Sep 30, 2014 · filed Nov 10, 2014 · 41 d after period end